C-Rad AB (FRA:24C) Inventories, Inventories Adjustments : €0.00 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is C-Rad AB Inventories, Inventories Adjustments?

C-Rad AB's Inventories, Inventories Adjustments for the quarter that ended in Mar. 2025 was €0.00 Mil.

C-Rad AB Inventories, Inventories Adjustments Historical Data

The historical data trend for C-Rad AB's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB Inventories, Inventories Adjustments Chart

C-Rad AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Inventories, Inventories Adjustments

Get a 7-Day Free Trial

C-Rad AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Inventories, Inventories Adjustments	Get a 7-Day Free Trial															-	-	-	-	-

C-Rad AB Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.

C-Rad AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (FRA:24C) » Definitions » Inventories, Inventories Adjustments

Comparable Companies

Traded in Other Exchanges

CRAD B:Sweden 0R44:UK

Address

Sjukhusvagen 12K, Uppsala, SWE, 753 09

Website

https://www.c-rad.com

C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.

C-Rad AB Headlines

No Headlines